Diseases and Disorders > Cancer > Ovarian Cancer >

FDA Approves New Drug to Treat Platinum-Resistant Ovarian Cancer

Elahere receives accelerated approval in an important advancement for gynecologic cancers.
A gloved hand holds a vial of a drug for ovarian cancer as a green ribbon wraps around it.
Illustration by Jaelen Brock

Related Articles

A recent study comes up with a new answer, one that eventually could help with screening.
Determining risk for this deadly disease is difficult, but cutting-edge research shows promise.
STS partners with patients to educate future healthcare providers about this deadly disease.
A new imaging drug may help women diagnosed with the deadly disease.